相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2017)
Inflammatory Bowel Diseases (IBD) immunopathogenesis: A comprehensive review of inflammatory molecules
Jae Hyon Park et al.
AUTOIMMUNITY REVIEWS (2017)
Chemokine and cytokine levels in inflammatory bowel disease patients
Udai P. Singh et al.
CYTOKINE (2016)
Selected biologic markers of inflammation and activity of Crohn's disease
Jacek Karczewski et al.
AUTOIMMUNITY (2015)
Biomarkers of Inflammation in Inflammatory Bowel Disease
Bruce E. Sands
GASTROENTEROLOGY (2015)
Accuracies of Serum and Fecal S100 Proteins (Calprotectin and Calgranulin C) to Predict the Response to TNF Antagonists in Patients with Crohn's Disease
Gilles Boschetti et al.
INFLAMMATORY BOWEL DISEASES (2015)
The role and utility of faecal markers in inflammatory bowel disease
Frank S. Lehmann et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2015)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin
Taina Sipponen
DIGESTIVE DISEASES (2013)
Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring
Jose-Manuel Benitez et al.
GUT (2013)
Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study
Michael Manz et al.
BMC GASTROENTEROLOGY (2012)
Epidemiology and Natural History of Inflammatory Bowel Diseases
Jacques Cosnes et al.
GASTROENTEROLOGY (2011)
IL-17: intestinal effector or protector?
Ivan J. Fuss
MUCOSAL IMMUNOLOGY (2011)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Th1/Th17 Immune Response Is Induced by Mesenteric Lymph Node Dendritic Cells in Crohn's Disease
Atsushi Sakuraba et al.
GASTROENTEROLOGY (2009)
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
S. Brand
GUT (2009)
Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage
D. Foell et al.
GUT (2009)
A protective function for interleukin 17A in T cell-mediated intestinal inflammation
William O'Connor et al.
NATURE IMMUNOLOGY (2009)
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
Jennifer Jones et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Microbial influences in inflammatory bowel diseases
R. Balfour Sartor
GASTROENTEROLOGY (2008)
C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study
M. Henriksen et al.
GUT (2008)
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease
CA Solem et al.
INFLAMMATORY BOWEL DISEASES (2005)
C-reactive protein as a marker for inflammatory bowel disease
S Vermeire et al.
INFLAMMATORY BOWEL DISEASES (2004)
A simple method for assessing intestinal inflammation in Crohn's disease
J Tibble et al.
GUT (2000)
分享论文
